Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
All products mentioned in this article are sold by Durham Peptides for research and laboratory use only
The acquired resistance of tumor cells to TKIs is partially reversed by inhibiting IGFBP-1 and the combination of antiangiogenic TKIs and IGFBP-1 inhibitors may be a promising therapeutic strategy for HCC (135)
B12 shots are safe when administered by a healthcare professional following proper guidelines and precautions
More comprehensive lipidomic analyses of the blood and liver from WT and KO mice are currently underway
US$ 26.36
US$ 26.63
US$ 20.10
US$ 21.43
US$ 28.25
